Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Health
Biotech
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

You have questions on genome-editing. We have answers

  • Adam Feuerstein
  • Sharon Begley

By Adam Feuerstein and Sharon Begley Feb. 27, 2018

Reprints
Mail bag
Justin Sullivan/Getty Images

Turns out, there are a lot of questions about genome-editing these days.

Last week we hosted an hourlong webinar on the subject. We also took questions from participants. It was great!

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Authors Reprints

Adam Feuerstein

Adam Feuerstein

Senior Writer, Biotech

Adam Feuerstein is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. He's also a co-host of "The Readout LOUD" podcast.

Sharon Begley

Sharon Begley

Senior Writer, Science and Discovery (1956-2021)

Sharon covered science and discovery.

Tags

Texas judge strikes down major Obamacare provision protecting preventive…
Texas judge strikes down major Obamacare provision protecting preventive care
Former J&J exec, an in-demand free agent, takes the…
Former J&J exec, an in-demand free agent, takes the helm at privately held FogPharma
Solicitor General urges Supreme Court to review ‘skinny labeling’…
Solicitor General urges Supreme Court to review ‘skinny labeling’ and generic drug access
Drug middlemen switch tactics, but the outcome is the…
Drug middlemen switch tactics, but the outcome is the same: high prices
FDA proposes a new plan to streamline updates to…
FDA proposes a new plan to streamline updates to medical devices that use AI
Pharmalittle: FDA approves over-the-counter Narcan; J&J exits the race…
Pharmalittle: FDA approves over-the-counter Narcan; J&J exits the race for the first RSV vaccine

Recommended Stories